-----BEGIN PRIVACY-ENHANCED MESSAGE----- Proc-Type: 2001,MIC-CLEAR Originator-Name: webmaster@www.sec.gov Originator-Key-Asymmetric: MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB MIC-Info: RSA-MD5,RSA, UvelaejM4LW2z3oZeGKXxdl5hhrUNp9oXfq2XxRf3egOqtIFKoPrv4EVabVWxcp6 NzXkKisGkJMa3A6VEYz4HQ== 0000936392-97-000144.txt : 19970222 0000936392-97-000144.hdr.sgml : 19970222 ACCESSION NUMBER: 0000936392-97-000144 CONFORMED SUBMISSION TYPE: SC 13G/A PUBLIC DOCUMENT COUNT: 1 FILED AS OF DATE: 19970212 SROS: NASD SUBJECT COMPANY: COMPANY DATA: COMPANY CONFORMED NAME: ISIS PHARMACEUTICALS INC CENTRAL INDEX KEY: 0000874015 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 330336973 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: SC 13G/A SEC ACT: 1934 Act SEC FILE NUMBER: 005-41771 FILM NUMBER: 97525554 BUSINESS ADDRESS: STREET 1: 2292 FARADAY AVE CITY: CARLSBAD STATE: CA ZIP: 92008 BUSINESS PHONE: 6199319200 MAIL ADDRESS: STREET 1: 2292 FARADAY AVE CITY: CARLSBAD STATE: CA ZIP: 92008 FILED BY: COMPANY DATA: COMPANY CONFORMED NAME: CROOKE STANLEY T CENTRAL INDEX KEY: 0000897667 STANDARD INDUSTRIAL CLASSIFICATION: [] FILING VALUES: FORM TYPE: SC 13G/A BUSINESS ADDRESS: STREET 1: C/O ISIS PHARMACEUTICALS INC STREET 2: 2292 FARADAY AVENUE CITY: CARLSBAD STATE: CA ZIP: 92008 BUSINESS PHONE: 6196032301 SC 13G/A 1 AMENDMENT NO. 5 TO SCEHDULE 13G 1 UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 SCHEDULE 13G (Amendment No. 5)* UNDER THE SECURITIES EXCHANGE ACT OF 1934 Isis Pharmaceuticals, Inc. (Name of Issuer) Common Stock (Title of Class of Securities) 464330 10 9 (CUSIP Number) *The remainder of this cover page shall be filled out for a reporting person's initial filing on this form with respect to the subject class of securities, and for any subsequent amendment containing information which would alter the disclosures provided in a prior cover page. The information required in the remainder of this cover page shall not be deemed to be "filed" for the purpose of Section 18 of the Securities Exchange Act of 1934 ("Act") or otherwise subject to the liabilities of that section of the Act but shall be subject to all other provisions of the Act (however, see the Notes). Page 1 of 4 pages 2 13G CUSIP NO. 464330 10 9 PAGE 2 OF 4 PAGES 1 NAME OF REPORTING PERSONS S.S. OR I.R.S. IDENTIFICATION NOS. OF ABOVE PERSONS STANLEY T. CROOKE ###-##-#### 2 CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP* (a) [ ] (b) [X] 3 SEC USE ONLY 4 CITIZENSHIP OR PLACE OF ORGANIZATION UNITED STATES 5 SOLE VOTING POWER NUMBER OF 1,209,519 (1) SHARES 6 SHARED VOTING POWER BENEFICIALLY OWNED BY 0 EACH REPORTING PERSON WITH 7 SOLE DISPOSITIVE POWER 1,209,519 (1) 8 SHARED DISPOSITIVE POWER 0 9 AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON 1,209,519 (1) 10 CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES* 11 PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW 9 4.6% 12 TYPE OF REPORTING PERSON* IN (1) includes 93,974 shares of Common Stock issuable upon exercise of options exercisable within 60 days. Also includes 6,045 shares issuable upon exercise of stock options held by Rosanne Crooke, Dr. Crooke's wife, exercisable on or before 3/1/97, as to which Dr. Crooke disclaims beneficial ownership. *SEE INSTRUCTION BEFORE FILLING OUT! Page 2 of 4 pages 3 ITEM 1. (a) Name of Issuer: Isis Pharmaceuticals, Inc. ("Issuer") (b) Address of Issuer's Principal Executive Offices: 2292 Faraday Avenue Carlsbad, CA 92008 ITEM 2. (a) Name of Person Filing: Stanley T. Crooke (b) Address of Principal Business Office or, if none, Residence: 2292 Faraday Avenue Carlsbad, CA 92008 (c) Citizenship: United States (d) Title of Class of Securities: Common Stock (e) CUSIP Number: 464330 10 9 ITEM 3. NOT APPLICABLE. ITEM 4. OWNERSHIP. (a) Amount Beneficially Owned: 1,209,519 (2) (b) Percent of Class: 4.6% (c) Number of shares as to which such person has: (i) sole power to vote or to direct the vote: 1,209,519 (2) (ii) shares power to vote or to direct the vote: 0 (iii) sole power to dispose or to direct the disposition of: 1,209,519 (2) (iv) shared power to dispose or to direct the disposition of:0 ITEM 5. OWNERSHIP OF FIVE PERCENT OR LESS OF A CLASS If this statement is being filed to report the fact that as of the date hereof the reporting person has ceased to be the beneficial owner of more than five percent of the class of securities, check the following: [X] ITEM 6. OWNERSHIP OF MORE THAN FIVE PERCENT ON BEHALF OF ANOTHER PERSON Not applicable ITEM 7. IDENTIFICATION AND CLASSIFICATION OF THE SUBSIDIARY WHICH ACQUIRED THE SECURITY BEING REPORTED ON BY THE PARENT HOLDING COMPANY. Not applicable. ITEM 8. IDENTIFICATION AND CLASSIFICATION OF MEMBERS OF THE GROUP Not applicable. (2) includes 93,974 shares of Common Stock issuable upon exercise of options exercisable within 60 days. Also includes 6,045 shares issuable upon exercise of stock options held by Rosanne Crooke, Dr. Crooke's wife, exercisable on or before 3/1/97, as to which Dr. Crooke disclaims beneficial ownership. Page 3 of 4 pages 4 ITEM 9. NOTICE OF DISSOLUTION OF GROUP Not applicable. ITEM 10. CERTIFICATION Not applicable SIGNATURE After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct. January 30, 1997 ----------------------------------- Date /s/ Stanley T. Crooke ----------------------------------- Signature Stanley T. Crooke, Chairman and CEO ----------------------------------- Name/Title Page 4 of 4 pages -----END PRIVACY-ENHANCED MESSAGE-----